Zoledronic Acid After Combo Tx Preserves BMD

(MedPage Today) -- A single dose of zoledronic acid (Reclast) given after 15 months of combination therapy with teriparatide (Forteo) and denosumab (Prolia) largely maintained the bone mineral density (BMD) gains in postmenopausal women with osteoporosis...